Personalis PSNL 深 滬
已收盤 10-31 16:00:00 美东时间
9.64
+0.130
+1.37%
華盛通- 最 高9.855
- 今 開9.51
- 成交量 72.62万股
- 最 低 9.30
- 昨 收 9.51
- 總市值 8.55亿
- 52周最高 10.95
- 市盈率 靜 --
- 換手率 0.82%
- 52周最低 2.8262
- 委 比 67.86%
- 總股本 8867.71万
- 歷史最高 53.46
- 量 比 0.81
- 振 幅 5.84%
- 歷史最低 0.8906
- 每 手 1
- 風險率 1.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
美股牛股 | PRAX暴涨逾180%！在原发性震颤治疗领域取得重大突破；生物技术股WHWK涨超24%
PRAX暴涨逾180%！在原发性震颤治疗领域取得重大突破；WHWK涨超24%，与Tempus AI建立战略伙伴关系，共同推进肿瘤研究领域发展>>
10-17 17:43
Personalis Announces Phase 3 LAURA Trial Data With AstraZeneca Showing NeXT Personal MRD Test Effectively Assesses Post-CRT Response In EGFRm Stage III NSCLC
Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (LAURA). The findings demonstrate that Personalis' highly
10-16 21:08
Klarna and Google Cloud Announce AI-First Partnership To Deliver Personalized Shopping And Creative Content To Users
Klarna, the global digital bank and flexible payments provider, and Google Cloud announced today a strategic, AI-first partnership to accelerate innovation, creativity, and customer-centric products to Klarna's more than
10-09 20:43
Personalis shares are trading higher after the company announced a collaboration with the Yale Cancer Center for a clinical trial titled "A single arm phase II trial of circulating tumor DNA-guided adjuvant therapy with elacestrant in hormone receptor positive HER2 negative breast cancers at risk for late recurrence (CATE)."
Personalis shares are trading higher after the company announced a collaboratio...
09-11 23:32
Personalis reports data from lung cancer trial
Personalis (NASDAQ:PSNL) has shared new results from a late-stage trial conducted by AstraZeneca (AZN) focused on lung cancer. The results indicate that Personalis’ advanced molecular residual disease...
09-04 05:31
Personalis Announces New Data From Astrazeneca Phase 3 Clinical Trial In Lung Cancer, Showing Personalis' MRD Test, NeXt Personal, Is Strong Predictor Of Outcomes In Patients With Stage II-IIIb, EGFR-Mutated NSCLC Receiving Neoadjuvant Therapy
Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (NeoADAURA). The findings demonstrate that Personalis'
09-04 04:19
Personalis gains as VA awards work order worth up to $13.5M
Shares of Personalis (NASDAQ:PSNL) added ~5% in the premarket on Friday after the cancer test maker announced that it received a new task order worth up to $13.5M under a contract with the Department ...
08-22 18:59
Cathie Wood's Thursday Bet: ARK Just Bought $31 Million Worth Of Falling Deere Stock, Also Loads Up On Block, Robinhood Shares
Ark Invest, led by Cathie Wood, made significant trades on Thursday — focusing on Deere & Co. (NYSE:DE), Block Inc. (NYSE:XYZ) and Robinhood Markets Inc. (NASDAQ:
08-15 09:49
8月13日外盘头条：特朗普考虑起诉鲍威尔 抨击高盛对关税判断 美国务卿与俄外长通话 木头姐大举买入Block
全球财经媒体昨夜今晨共同关注的头条新闻主要有： 1、白宫称特朗普正考虑就美联储主席鲍威尔的翻修工程提起诉讼 2、美国国务卿鲁比...
08-13 05:30
